Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Even if only partially effective, such a vaccine could be a much-needed compensation for treatment as prevention’s shortcomings.
Act out for health equity with Young Invincibles, #WellnessWed, Twitter chats and these sharable LGBT and HIV facts.
A study of gay and bi men in late 2015 found that two thirds were PrEP candidates but less than 1 in 10 of those men were taking it.
David & Johnny dish on what they would have told their “Former Selves” and give views you can use!
It is unclear how going on Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) may have affected these rates.
The organization will keep the two original names: Rocky Mountain CARES and the AIDS Resource Center of Wisconsin.
A look at the most notable HIV-related studies presented at the 2017 Conference on Retroviruses and Opportunistic Infections in Seattle.
We are changing the conference's name from the National HIV PrEP Summit to the Biomedical HIV Prevention Summit.
So why is he taking meds every day?
The Dutch man was engaging in very high-risk sex and adhering well to the daily Truvada regimen.
However, might post-exposure prophylaxis (PEP) against STIs impact resistance to antibiotics among infections like gonorrhea?
This challenges a finding that an anti-HIV vaginal gel might not be effective in women with abnormal vaginal flora.
A major study’s finding has assuaged concerns that HIV drugs can compromise how well birth control works.
Researchers conducted a trial in monkeys to investigate potential risks posed by long-acting injectable cabotegravir as HIV prevention.
The CDC estimates that annual new HIV infections declined 18 percent between 2008 and 2014.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.